← All Sponsors
SPONSOR

iOnctura

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Myelofibrosis (MF)
NCT06887803 Phase 1, Phase 2
Recruiting

A Study of Roginolisib in Combination With Ruxolitinib in Patients With Myelofibrosis (MF) Who Are Unresponsive to JAK Inhibitors

Myelofibrosis (MF)
Italy, Spain View Trial →